{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:14:11Z","timestamp":1791962051676,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,3,23]],"date-time":"2010-03-23T00:00:00Z","timestamp":1269302400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s11882-010-0101-7","type":"journal-article","created":{"date-parts":[[2010,3,22]],"date-time":"2010-03-22T06:50:09Z","timestamp":1269240609000},"page":"155-162","source":"Crossref","is-referenced-by-count":8,"title":["Modern Approach to Managing Vernal Keratoconjunctivitis"],"prefix":"10.1007","volume":"10","author":[{"given":"Sunil","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Vivian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,23]]},"reference":[{"key":"101_CR1","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Kumar S: Vernal keratoconjunctivitis: a major review. Acta Ophthalmol 2009, 87:133\u2013147. This is a comprehensive review.","DOI":"10.1111\/j.1755-3768.2008.01347.x"},{"key":"101_CR2","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Bonini S, Sacchetti M, Mantelli F, Lambiase A: Clinical grading of vernal keratoconjunctivitis. Curr Opin Allergy Clin Immunol 2007, 7:436\u2013441. This article introduced a new grading system based on severity of disease; a treatment plan for different grades is also discussed.","DOI":"10.1097\/ACI.0b013e3282efb726"},{"key":"101_CR3","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Mantelli F, Santos MS, Petitti T, et al.: Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis. Br J Opthalmol 2007, 91:1656\u20131661. This was a meta-analysis of randomized controlled trials on the efficacy of currently available topical drugs for VKC.","DOI":"10.1136\/bjo.2007.122044"},{"key":"101_CR4","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2165\/00003495-200262110-00004","volume":"62","author":"L Bielory","year":"2002","unstructured":"Bielory L: Ocular allergy guidelines: a practical treatment algorithm. Drugs 2002, 62:1611\u20131634.","journal-title":"Drugs"},{"key":"101_CR5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1350-9462(02)00006-X","volume":"21","author":"A Leonardi","year":"2002","unstructured":"Leonardi A: Vernal keratoconjunctivitis: pathogenesis and treatment. Prog Retin Eye Res 2002, 21:319\u2013339.","journal-title":"Prog Retin Eye Res"},{"key":"101_CR6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/archopht.1997.01100150036004","volume":"115","author":"CNS Soparkar","year":"1997","unstructured":"Soparkar CNS, Wilhelmus KR, Koch DD, et al.: Acute and chronic conjunctivitis due to over-the-counter ophthalmic decongestants. Arch Ophthalmol 1997, 115:34\u201338.","journal-title":"Arch Ophthalmol"},{"key":"101_CR7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00130832-200210000-00009","volume":"2","author":"MK Church","year":"2002","unstructured":"Church MK, McGill JI: Human ocular mast cells. Curr Opin Allergy Clin Immunol 2002, 2:419\u2013422.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"101_CR8","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1001\/archopht.1977.04450120090009","volume":"95","author":"KF Tabbara","year":"1977","unstructured":"Tabbara KF, Arafat NT: Cromolyn effects on vernal keratoconjuctivitis in children. Arch Ophthalmol 1977, 95:2184\u20132186.","journal-title":"Arch Ophthalmol"},{"key":"101_CR9","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/eye.1992.139","volume":"6","author":"S Bonini","year":"1992","unstructured":"Bonini S, Barney NP, Schiavone M, et al.: Effectiveness of nedocromil sodium 2% eye drops on clinical symptoms and tear fluid cytology of patients with vernal conjunctivitis. Eye 1992, 6:648\u2013652.","journal-title":"Eye"},{"key":"101_CR10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0002-9394(14)74786-5","volume":"113","author":"DR Caldwell","year":"1992","unstructured":"Caldwell DR, Verin P, Hartwich-Young R, et al.: Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitis. Am J Ophthalmol 1992, 113:632\u2013637.","journal-title":"Am J Ophthalmol"},{"key":"101_CR11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/00003495-198631020-00003","volume":"31","author":"EM Sorkin","year":"1986","unstructured":"Sorkin EM, Ward A: Ocular sodium cromoglycate, an overview of its therapeutic efficacy in allergic eye disease. Drugs 1986, 31:131\u2013148.","journal-title":"Drugs"},{"key":"101_CR12","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/bjo.67.10.688","volume":"67","author":"E Dahan","year":"1983","unstructured":"Dahan E, Appel R: Vernal conjunctivitis in the black child and its response to therapy. Br J Ophthalmol 1983, 67:688\u2013692.","journal-title":"Br J Ophthalmol"},{"key":"101_CR13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/bjo.81.1.23","volume":"81","author":"A Leonardi","year":"1997","unstructured":"Leonardi A, Borghesan F, Avarello A, et al.: Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis. Br J Ophthalmol 1997, 81:23\u201326.","journal-title":"Br J Ophthalmol"},{"key":"101_CR14","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0161-6420(00)00089-0","volume":"107","author":"AM Avunduk","year":"2000","unstructured":"Avunduk AM, Avunduk MC, Kapicioglu Z, et al.: Mechanisms and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitis. Ophthalmology 2000, 107:1333\u20131337.","journal-title":"Ophthalmology"},{"key":"101_CR15","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/112067210101100203","volume":"11","author":"P Verin","year":"2001","unstructured":"Verin P, Allewaert R, Joyaux JC, et al.; Lodoxamide Study Group: Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis. Eur J Ophthalmol 2001, 11:120\u2013125.","journal-title":"Eur J Ophthalmol"},{"key":"101_CR16","first-page":"451","volume":"54","author":"CG Owen","year":"2004","unstructured":"Owen CG, Shah A, Henshaw K, et al.: Topical treatment for seasonal allergic conjunctivitis: systematic review and meta-analysis of efficacy and effectiveness. Br J Gen Pract 2004, 54:451\u2013456.","journal-title":"Br J Gen Pract"},{"key":"101_CR17","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000069459","volume":"115","author":"LK Weimer","year":"1998","unstructured":"Weimer LK, Gamache DA, Yanni JM: Histamine-stimulated cytokine secretion from human conjunctival epithelial cells: inhibition by the histamine H1 antagonist emedastine. Int Arch Allergy Immunol 1998, 115:288\u2013293.","journal-title":"Int Arch Allergy Immunol"},{"key":"101_CR18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003495-200565020-00004","volume":"65","author":"L Bielory","year":"2005","unstructured":"Bielory L, Lien KW, Bigelsen S: Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis. Drugs 2005, 65:215\u2013228.","journal-title":"Drugs"},{"key":"101_CR19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10792-004-1818-x","volume":"25","author":"JI McGill","year":"2004","unstructured":"McGill JI: A review of the use of olopatadine in allergic conjunctivitis. Int Ophthalmol 2004, 25:171\u2013179.","journal-title":"Int Ophthalmol"},{"key":"101_CR20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1089\/jop.2005.21.400","volume":"21","author":"I Corum","year":"2005","unstructured":"Corum I, Yeniad B, Bilgin LK, Ilhan R: Efficiency of olopatadine hydrochloride 0.1% in the treatment of vernal keratoconjunctivitis and goblet cell density. J Ocul Pharmacol Ther 2005, 21:400\u2013405.","journal-title":"J Ocul Pharmacol Ther"},{"key":"101_CR21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00417-002-0612-6","volume":"241","author":"G D\u2019Angelo","year":"2003","unstructured":"D\u2019Angelo G, Lambiase A, Cortes M, et al.: Preservative-free diclofenac sodium 0.1% for vernal keratoconjunctivitis. Graefes Arch Clin Exp Ophthalmol 2003, 241:192\u2013195.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"101_CR22","first-page":"177","volume":"45","author":"A Sharma","year":"1997","unstructured":"Sharma A: Topical ketarolac 0.5% solution for the treatment of vernal keratoconunctivitis. Indian J Ophthalmol 1997, 45:177\u2013180.","journal-title":"Indian J Ophthalmol"},{"key":"101_CR23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.ICL.0000092071.82938.46","volume":"30","author":"H Ilyas","year":"2004","unstructured":"Ilyas H, Slonim CB, Braswell GR, et al.: Long term efficacy of loteprednol etabonalte 0.2% in the treatment of seasonal and perennial allergic conjunctivitis. Eye Contact Lens 2004, 30:10\u201313.","journal-title":"Eye Contact Lens"},{"key":"101_CR24","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00003226-200207000-00008","volume":"21","author":"A Leonardi","year":"2002","unstructured":"Leonardi A, Papa V, Milazzo G, Secchi AG: Efficacy and safety of desonide phosphate for the treatment of allergic conjunctivitis. Cornea 2002, 21:476\u2013481.","journal-title":"Cornea"},{"key":"101_CR25","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1034\/j.1600-0420.1999.770505.x","volume":"77","author":"JS Saini","year":"1999","unstructured":"Saini JS, Gupta A, Pandey SK, et al.: Efficacy of supratarsal dexamethasone versus triamcinolone injection in recalcitrant vernal keratoconjunctivitis. Acta Ophthalmol Scand 1999, 77:515\u2013518.","journal-title":"Acta Ophthalmol Scand"},{"key":"101_CR26","first-page":"160","volume":"50","author":"S Singh","year":"2002","unstructured":"Singh S, Pal V, Dhull CS: Supratarsal injection of corticosteroids in the treatment of refractory vernal keratoconjunctivitis. Indian J Ophthalmol 2002, 50:160\u2013161.","journal-title":"Indian J Ophthalmol"},{"key":"101_CR27","first-page":"19","volume":"41","author":"M Lisanework","year":"2003","unstructured":"Lisanework M: Supra-tarsal injection of dexamethasone in the treatment of patients with refractory vernal keratoconjunctivitis. Ethiop Med J 2003, 41:19\u201324.","journal-title":"Ethiop Med J"},{"key":"101_CR28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0002-9394(14)70271-5","volume":"121","author":"DS Holsclaw","year":"1996","unstructured":"Holsclaw DS, Whitcher JP, Wong IG, Margolis TP: Supratarsal injection of corticosteroid in the treatment of refractory vernal keratoconjunctivitis. Am J Ophthalmol 1996, 121:243\u2013249.","journal-title":"Am J Ophthalmol"},{"key":"101_CR29","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0002-9394(86)90819-6","volume":"101","author":"D BenEzra","year":"1986","unstructured":"BenEzra D, Pe\u2019er J, Brodsky M, Cohen E: Cyclosporine eye drops for the treatment of severe vernal keratoconjunctivitis. Am J Ophthalmol 1986, 101:278\u2013282.","journal-title":"Am J Ophthalmol"},{"key":"101_CR30","doi-asserted-by":"crossref","unstructured":"Abu El-Asrar AM, Tabbara KF, Geboes K, et al.: An immunohistochemical study of topical cyclosporine in vernal keratoconjunctivitis. Am J Ophthalmol 1996, 121:156\u2013161.","DOI":"10.1016\/S0002-9394(14)70579-3"},{"key":"101_CR31","first-page":"644","volume":"20","author":"D BenEzra","year":"1988","unstructured":"BenEzra D, Matamoros N, Cohen E: Treatment of severe vernal keratoconjunctivitis with cyclosporine A eye drops. Transplant Proc 1988, 20:644\u2013649.","journal-title":"Transplant Proc"},{"key":"101_CR32","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9394(14)77061-8","volume":"110","author":"AG Secchi","year":"1990","unstructured":"Secchi AG, Tognon MS, Leonardi A: Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis. Am J Ophthalmol 1990, 110:641\u2013645.","journal-title":"Am J Ophthalmol"},{"key":"101_CR33","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1001\/archopht.119.10.1512","volume":"119","author":"A Leonardi","year":"2001","unstructured":"Leonardi A, DeFranchis G, Fregona IA, et al.: Effects of cyclosporin A on human conjunctival fibroblasts. Arch Ophthalmol 2001, 119:1512\u20131517.","journal-title":"Arch Ophthalmol"},{"key":"101_CR34","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1081-1206(10)61958-8","volume":"89","author":"N Pucci","year":"2002","unstructured":"Pucci N, Novembre E, Cianferoni A, et al.: Efficacy and safety of cyclosporine eye drops in vernal keratoconjunctivitis. Ann Allergy Asthma Immunol 2002, 89:298\u2013303.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"101_CR35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3129\/i06-061","volume":"41","author":"A Kilic","year":"2006","unstructured":"Kilic A, Gurler B: Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis. Can J Ophthalmol 2006, 41:693\u2013698.","journal-title":"Can J Ophthalmol"},{"key":"101_CR36","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000050876","volume":"215","author":"AM Avunduk","year":"2001","unstructured":"Avunduk AM, Avunduk MC, Erdol H, et al.: Cyclosporine effects on clinical findings and impression cytology specimens in severe vernal keratoconjunctivitis. Ophthalmologica 2001, 215:290\u2013293.","journal-title":"Ophthalmologica"},{"key":"101_CR37","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1399-3038.2006.00427.x","volume":"17","author":"L Spadavecchia","year":"2006","unstructured":"Spadavecchia L, Fanelli P, Tesse R, et al.: Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood. Pediatr Allergy Immunol 2006, 17:527\u2013532.","journal-title":"Pediatr Allergy Immunol"},{"key":"101_CR38","first-page":"190","volume":"87","author":"P Kosrirukvongs","year":"2004","unstructured":"Kosrirukvongs P, Luengchaichawange C: Topical cyclosporine 0.5 per cent and preservative-free ketorolac tromethamine 0.5 per cent in vernal keratoconjunctivitis. J Med Assoc Thai 2004, 87:190\u2013197.","journal-title":"J Med Assoc Thai"},{"key":"101_CR39","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00003226-200403000-00014","volume":"23","author":"A Cetinkaya","year":"2004","unstructured":"Cetinkaya A, Akova YA, Dursun D, Pelit A: Topical cyclosporine in the management of shield ulcers. Cornea 2004, 23:194\u2013200.","journal-title":"Cornea"},{"key":"101_CR40","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/ICO.0b013e31812dfab3","volume":"26","author":"AA Ozcan","year":"2007","unstructured":"Ozcan AA, Ersoz TR, Dulger E: Management of severe allergic conjunctivitis with topical cyclosporine 0.05% eye drops. Cornea 2007, 26:1035\u20131038.","journal-title":"Cornea"},{"key":"101_CR41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1444-0938.2007.00183.x","volume":"91","author":"S Kumar","year":"2008","unstructured":"Kumar S: Combined therapy of vernal shield ulcer: a case report. Clin Exp Optom 2008, 91:111\u2013114.","journal-title":"Clin Exp Optom"},{"key":"101_CR42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0161-6420(99)00096-2","volume":"107","author":"EK Akpek","year":"2000","unstructured":"Akpek EK, Hasiripi H, Christen WG, Kalayci D: A randomized trial of low-dose, topical mitomycin-C in the treatment of severe vernal keratoconjunctivitis. Ophthalmology 2000, 107:263\u2013269.","journal-title":"Ophthalmology"},{"key":"101_CR43","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/0301-4738.25832","volume":"54","author":"AK Jain","year":"2006","unstructured":"Jain AK, Sukhija J: Low dose mitomycin-C in severe vernal keratoconjunctivitis: a randomized prospective double blind study. Indian J Ophthalmol 2006, 54:111\u2013116.","journal-title":"Indian J Ophthalmol"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-010-0101-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-010-0101-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-010-0101-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:42:23Z","timestamp":1559432543000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-010-0101-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,23]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["101"],"URL":"https:\/\/doi.org\/10.1007\/s11882-010-0101-7","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,23]]}}}